An azoospermia diagnosis should not stop at a single laboratory result stating “no sperm found.” In good practice, this diagnosis needs to be confirmed through proper semen analysis, repeated testing if necessary, and further evaluation to understand whether the cause points more towards a blockage or a sperm production disorder.
For couples, the testing phase often feels exhausting because the answers don’t come all at once. However, this is precisely where the best foundation for treatment decisions is built, because azoospermia therapy heavily relies on the results of initial testing.
Azoospermia diagnosis usually begins with a semen analysis
The earliest step in diagnosing azoospermia is a semen analysis. The WHO places semen examination as the basic standard for male fertility evaluation, and the American Urological Association (AUA) along with the American Society for Reproductive Medicine (ASRM) define azoospermia as the absence of sperm in the ejaculate, including after examining the centrifuged semen pellet (spun at high speed to separate and collect sperm that might be present in very small amounts).
This means an “empty” result on the report might not be sufficient if the laboratory examination is incomplete. In suspected NOA (Non-Obstructive Azoospermia — a condition where the testicles do not produce sperm normally), the European Association of Urology (EAU) guidelines recommend confirmation on two consecutive semen analyses when no sperm is found after centrifugation.
Besides the presence or absence of sperm, doctors also look at semen volume, pH, and other clinical contexts. A very low volume and acidic pH can provide clues pointing towards ejaculatory duct obstruction or abnormalities of the vas deferens (the tube that carries sperm from the testicles to the urethra).
Azoospermia diagnosis continues with medical history and physical examination
Once the semen results point to azoospermia, the doctor usually enters the medical history and physical examination stage. A history of hernia or scrotal surgery, infections, undescended testicles (cryptorchidism), exposure to substances harmful to the testicles such as chemotherapy or radiation, testosterone use, puberty disorders, and family history can provide important clues.
The physical examination is also crucial because testicular size, epididymal condition, and the state of the vas deferens during a physical exam can help differentiate the type of azoospermia. The AUA/ASRM emphasizes that the combination of history, physical examination, and hormone testing is often sufficient to help distinguish obstructive from non-obstructive azoospermia without routine diagnostic biopsies.
At this point, couples often begin to get an idea of whether the issue is more likely “a blocked exit pathway” or “impaired sperm production.” Both are equally serious, but the follow-up pathways are vastly different.
Hormone testing, imaging, and genetic tests in azoospermia diagnosis
Azoospermia diagnosis often requires hormone testing, particularly FSH and testosterone, and then LH or prolactin if there are specific indications. According to the AUA/ASRM, an azoospermic man with small testicles, high FSH, and normal semen volume usually points more toward NOA, whereas normal testicular volume with lower FSH could point toward an obstructive cause.
Genetic testing is also important for certain patients. The AUA/ASRM and EAU suggest chromosome testing (karyotype) and Y-chromosome microdeletion testing in men with azoospermia or severe sperm production disorders. In addition, CFTR testing (Cystic Fibrosis Transmembrane Conductance Regulator — an examination of the gene which, if mutated, can cause the sperm ducts to not form from birth) should be considered if there is suspicion of CBAVD (Congenital Bilateral Absence of the Vas Deferens — a condition where the vas deferens fails to form from birth on both sides). In the 2024 AUA/ASRM guideline update, Y-chromosome microdeletions are estimated to be found in about 8–12% of men with NOA.
Imaging tests are not always performed for everyone. The AUA/ASRM states that TRUS (Transrectal Ultrasound — an ultrasound examination through the rectum) is more relevant if an ejaculatory duct blockage is suspected, for example, if semen volume is low, pH is acidic, and the vas deferens is still palpable during physical examination.
Once the azoospermia diagnosis is clear, treatment decisions become more directed
The ultimate goal of diagnosing azoospermia is not merely to assign a label, but to determine the most rational next step. If evaluation results point to an obstructive cause, couples can discuss sperm retrieval from the epididymis or testicles, ICSI (Intracytoplasmic Sperm Injection — a procedure of injecting a single sperm directly into an egg), or tract reconstruction in specific cases.
If results point to NOA, the doctor will assess whether the patient is suitable to be considered for micro-TESE, whether there are certain hormonal indications, or if genetic counseling is needed first. The EAU explicitly recommends micro-TESE as the sperm retrieval option of choice for NOA patients who are candidates for assisted reproductive programs.
At this stage, the evaluation of the female partner must not be left behind either. The AUA/ASRM emphasizes that infertility evaluations should run in parallel for both partners, because female factors greatly influence the most efficient strategy toward pregnancy.
Conclusion
Diagnosing azoospermia requires an orderly sequence of tests, starting from a proper semen analysis, followed by medical history, physical examination, hormone testing, and additional tests selected based on clinical suspicion. This step-by-step approach helps doctors distinguish obstructive from non-obstructive causes without jumping too quickly into unnecessary procedures.
The clearer your azoospermia diagnosis is, the more realistic the discussions about future chances, procedures, and family planning options will be. This often provides a sense of peace, because the couple is finally moving in a more certain direction.
Next Steps
If you already have a semen analysis result, the best step is usually to check if the evaluation is complete and whether re-confirmation or additional testing is needed.
Free HagiaMed Consultation — a free initial consultation with our specialists, with no cost and no commitment.
References
The following references form the basis of the testing and evaluation sequence for azoospermia used in this article.
• World Health Organization. WHO Laboratory Manual for the Examination and Processing of Human Semen, 6th ed.
• American Urological Association and American Society for Reproductive Medicine. Diagnosis and Treatment of Infertility in Men.
• European Association of Urology. Sexual and Reproductive Health Guidelines: Male Infertility.
Disclaimer: This information is educational in nature and does not replace a doctor’s evaluation. Diagnostic and therapeutic decisions must be tailored to the examination results of you and your partner.
